Statera Biopharma, Inc. Annual Return On Assets in % from 2012 to 2021

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Statera Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2021.
  • Statera Biopharma, Inc. Return On Assets for the quarter ending September 30, 2022 was -602 %, a 539% decline year-over-year.
  • Statera Biopharma, Inc. annual Return On Assets for 2021 was -276 %, a 41.8% increase from 2020.
  • Statera Biopharma, Inc. annual Return On Assets for 2020 was -474 %, a 398% decline from 2019.
  • Statera Biopharma, Inc. annual Return On Assets for 2019 was -95.1 %, a 68.9% decline from 2018.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 -276 +198 +41.8% Jan 1, 2021 Dec 31, 2021
2020 -474 -379 -398% Jan 1, 2020 Dec 31, 2020
2019 -95.1 -38.8 -68.9% Jan 1, 2019 Dec 31, 2019
2018 -56.3 Jan 1, 2018 Dec 31, 2018
2013 -89.2 -19.6 -28.2% Jan 1, 2013 Dec 31, 2013
2012 -69.6 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.